Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Unjha FormulationsBOM:531762 +1.68%67 Days Inventory is 18.14 as of Mar. 2026, which is 45% below its 10-year median of 32.81. GuruFocus rates BOM:531762 with a GF Score™ of 67/100 and a GF Value™ of ₹23.19 (Fairly Valued). Among 922 Drug Manufacturers companies, Unjha Formulations ranks better than 97.4% on this metric.
The historical rank and industry rank for Unjha Formulations's Days Inventory or its related term are showing as below:
BOM:531762'
s Days Inventory Range Over the Past 10 Years
Min: 20.73 Med: 32.81 Max: 40.37
Current: 31.36
During the past 13 years, Unjha Formulations's highest Days Inventory was 40.37. The lowest was 20.73. And the median was 32.81.
BOM:531762's Days Inventory is ranked better than 97.4% of 922
companies
in the Drug Manufacturers industry
Industry Median: 165.005
vs BOM:531762: 31.36
Unjha Formulations's Days Inventory
declined
from Mar. 2025 (42.64) to Mar. 2026 (18.14).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Unjha Formulations's Inventory Turnover for the
three
months ended in Mar. 2026 was 5.03.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Unjha Formulations's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.19.
Unjha Formulations (BOM:531762) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Unjha Formulations's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Unjha Formulations's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Unjha Formulations Days Inventory Related Terms
Unjha Formulations Days Inventory Historical Data
* Premium members only.
The historical data trend for Unjha Formulations's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Unjha Formulations's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Unjha Formulations Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Unjha Formulations's Days Inventory distribution charts can be found below:
* The bar in red indicates where Unjha Formulations's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Unjha Formulations (BOM:531762) has a Days Inventory of 18.14 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Unjha Formulations and its competitors. This is 45% below median its historical median of 32.81. Over the past decade, Unjha Formulations' Days Inventory has ranged from 20.73 to 40.37. According to the industry distribution chart, Unjha Formulations ranks #24 out of 922 companies in the Drug Manufacturers industry, placing it in the top 2.6%.
Is Unjha Formulations' Days Inventory too high?
Unjha Formulations' current Days Inventory of 18.14 is 45% below median its 10-year median of 32.81. Over the past 10 years, this metric has ranged from a low of 20.73 to a high of 40.37. The Drug Manufacturers industry median Days Inventory is 165.01. Unjha Formulations' value of 18.14 is 89% below this industry median. Based on the distribution chart, Unjha Formulations ranks #24 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Unjha Formulations has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Unjha Formulations' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Unjha Formulations ranks #24 out of 922 companies for Days Inventory. This places Unjha Formulations in the top 3% of its industry — outperforming the majority of peers. The industry median Days Inventory is 165.01. Unjha Formulations' value of 18.14 is 89% below this benchmark. Historically, Unjha Formulations' own Days Inventory has ranged from 20.73 to 40.37 over the past decade. While the company's 10-year median is 32.81 vs. the industry median of 165.01, Unjha Formulations has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.01, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Unjha Formulations's current Days Inventory of 18.14 is 89% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Unjha Formulations and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Unjha Formulations's current Days Inventory is 18.14, which is 45% below median its own 10-year median of 32.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unjha Formulations stock overvalued right now?
Based on GuruFocus' analysis, Unjha Formulations (BOM:531762) is currently considered Fairly Valued. The stock's GF Value™ is ₹23.19, compared to a current price of ₹24.25 — trading 4.6% above its estimated fair value. The current Days Inventory is 18.14, which is 45% below median its 10-year median of 32.81 and 89% below the Drug Manufacturers industry median of 165.01. Unjha Formulations' overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Unjha Formulations (BOM:531762), the current Days Inventory is 18.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Unjha Formulations (BOM:531762) Overvalued in 2026?
Based on GuruFocus' analysis, Unjha Formulations stock appears to be overvalued.
The current stock price of ₹24.25 is trading 4.6% above its estimated GF Value™ of ₹23.19.
GuruFocus considers Unjha Formulations to be Fairly Valued.
Key valuation signals for BOM:531762:
Days Inventory: 18.14 (45% below median its 10-year median of 32.81)
GF Value™: ₹23.19 vs. price of ₹24.25 (4.6% above fair value)
Industry Position: 89% below the Drug Manufacturers median (#24 of 922)
No single metric tells the full story. See the BOM:531762 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Unjha Formulations Ltd is an India-based manufacturer and exporter of Ayurvedic products. The company products include Isabgol powder under the Fibron and Fibron SF name, and Sat-Isabgol and Isabgol Husk. It also offers human and veterinary medicines.
67GF Score
Get the complete analysis for BOM:531762
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531762 has been successfully added to your 
